Omega Healthcare Investors (OHI) EBITDA (2009 - 2026)

Omega Healthcare Investors (OHI) has 16 years of EBITDA data on file, last reported at $215.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 21.37% year-over-year to $215.6 million; the trailing twelve-month figure through Mar 2026 stood at $888.2 million (up 31.09% YoY), and the FY2025 full-year result was $848.5 million, up 30.19% from the prior year.
• EBITDA declined to $215.6 million in Q1 2026, from $223.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $255.2 million in Q1 2022 to a low of $96.2 million in Q1 2023.
• A 5-year average of $168.2 million and a median of $161.0 million in 2024 frame the typical range for EBITDA.
• Across the five-year window, EBITDA sank 62.32% in 2023 and surged 50.24% in 2025, its largest moves.
• Tracing OHI's EBITDA over 5 years: stood at $106.5 million in 2022, then rose by 11.99% to $119.2 million in 2023, then soared by 35.01% to $161.0 million in 2024, then jumped by 38.54% to $223.0 million in 2025, then decreased by 3.34% to $215.6 million in 2026.
• Business Quant data shows OHI's EBITDA at $215.6 million in Q1 2026, $223.0 million in Q4 2025, and $249.5 million in Q3 2025.